Rxsight Research Development from 2010 to 2026
| RXST Stock | USD 8.69 0.22 2.47% |
Research Development | First Reported 2020-03-31 | Previous Quarter 10.2 M | Current Value 9.1 M | Quarterly Volatility 1.5 M |
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 30.8 K, Net Interest Income of 11.4 M or Interest Income of 11.4 M, as well as many indicators such as Price To Sales Ratio of 10.43, Dividend Yield of 0.0 or PTB Ratio of 2.34. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
Rxsight | Research Development | Build AI portfolio with Rxsight Stock |
The evolution of Research Development for Rxsight provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Rxsight compares to historical norms and industry peers.
Latest Rxsight's Research Development Growth Pattern
Below is the plot of the Research Development of Rxsight over the last few years. It is Rxsight's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Rxsight Research Development Regression Statistics
| Arithmetic Mean | 29,492,210 | |
| Geometric Mean | 29,278,025 | |
| Coefficient Of Variation | 12.56 | |
| Mean Deviation | 1,941,628 | |
| Median | 29,569,000 | |
| Standard Deviation | 3,705,513 | |
| Sample Variance | 13.7T | |
| Range | 17.6M | |
| R-Value | 0.19 | |
| Mean Square Error | 14.1T | |
| R-Squared | 0.04 | |
| Significance | 0.46 | |
| Slope | 139,886 | |
| Total Sum of Squares | 219.7T |
Rxsight Research Development History
About Rxsight Financial Statements
Rxsight shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 39.5 M | 30.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.